Lee, Kirsty Wai Chung
Lord, Sally
Finn, Richard S.
Lim, Elgene
Martin, Andrew
Loi, Sherene
Lynch, Jodi
Friedlander, Michael
Lee, Chee Khoon
Article History
Received: 1 August 2018
Accepted: 16 November 2018
First Online: 21 November 2018
Compliance with ethical standards
:
: RSF acted as a consultant for Astra Zeneca, Bayer, Bristol Myers Squibb, Eisai, Eli Lilly, Novartis, Merck, Pfizer. EL received research funding from Novartis Australia and Bayer (to the institution); acted as a consultant for Novartis Australia, Pfizer Australia, Roche Australia. SL received research funding from Novartis, Bristol Meyers Squibb, Merck, Roche-Genentech, Puma Biotechnology, and Pfizer (to the institution); acted as a consultant for Seattle Genetics, Pfizer, Novartis, BMS, Merck, and Roche-Genentech. MF received remuneration and acted as a consultant for AstraZeneca and MSD. CKL received remuneration and acted as a consultant for AstraZeneca, Roche, Takeda, Boehringer Ingelheim, Novartis. All remaining authors have declared no conflict of interest.
: This research work is a meta-analysis of published data and does not contain any direct involvement of human participants.